These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 28422845

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J.
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neuroleptic Malignant Syndrome with Normal Creatine Phosphokinase Levels: An Atypical Presentation.
    Zaidi S, Irfan N, Khalid Z.
    J Coll Physicians Surg Pak; 2022 Apr; 32(4):S47-S48. PubMed ID: 35633010
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Patient with encephalitis presenting with olanzapine-responsive malignant catatonia].
    Suzuki H, Fukushima T, Makino K, Kuwabara T.
    Rinsho Shinkeigaku; 2010 May; 50(5):329-31. PubMed ID: 20535983
    [Abstract] [Full Text] [Related]

  • 30. An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome.
    White DA, Robins AH.
    CNS Spectr; 2000 Jul; 5(7):58-65. PubMed ID: 18197157
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature.
    Belteczki Z, Ujvari J, Dome P.
    Clin Neuropharmacol; 2000 Jul; 44(4):148-153. PubMed ID: 34132673
    [Abstract] [Full Text] [Related]

  • 33. Clozapine in schizophrenia patients with recurrent catatonia: report of two cases.
    Hung YY, Yang PS, Huang TL.
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):256-8. PubMed ID: 16594953
    [Abstract] [Full Text] [Related]

  • 34. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
    Tsai JH, Yang P, Yen JY, Chen CC, Yang MJ.
    Pharmacotherapy; 2005 Aug; 25(8):1156-9. PubMed ID: 16207109
    [Abstract] [Full Text] [Related]

  • 35. Neuroleptic Malignant Syndrome or Catatonia? A Case Report.
    Rodriguez S, Dufendach KA, Weinreib RM.
    J Crit Care Med (Targu Mures); 2020 Jul; 6(3):190-193. PubMed ID: 32864466
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL, Taylor WH, Ware MR.
    Psychopharmacol Bull; 2001 Jul; 35(3):49-54. PubMed ID: 12397878
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S, Kornreich C, Choubani Z, Gourevitch R.
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [Abstract] [Full Text] [Related]

  • 40. A Case of Schizophrenia With Catatonia Resistant to Lorazepam and Olanzapine Monotherapy But Responsive to Combination Treatment: Is It Time to Consider Using Select Second-Generation Antipsychotics Earlier in the Treatment Algorithm for This Patient Type?
    Spiegel DR, Glad R, Smith M, Raja U, Wade R, Johnson K.
    Clin Neuropharmacol; 2019 Dec; 42(2):57-59. PubMed ID: 30762605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.